Skip to content
Toggle Navigation
Platform
Pipeline
Our Team
Our Story
Partnerships
News
Careers
Contact
Back to News
Categories:
News
|
Published On:
April 5
,
2022
|
Written by
Brandon Tilley
|
First-Ever Computationally Designed Antibody, Created by Biolojic Design, Entering Human Clinical Trial In Cancer Patients
Back to News
More News
Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024
Read More
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany.
Read More
BUSINESS AND MEDIA INQUIRIES
Micah Pearlman
micah@biolojic.com
Page load link
Go to Top